Copeptin is the carboxyl-terminus of the arginine vasopressin (AVP) precursor peptide. The
main physiological functions of AVP are fluid and osmotic balance, cardiovascular …

Increased neurohormonal activation is a key feature of heart failure (HF). Copeptin is a
surrogate marker for proarginine vasopressin and the prognostic value of copeptin has been …

Aims In heart failure, various biomarkers are established for diagnosis and risk stratification;
however, little is known about the relevance of serial measurements during an episode …

Biomarkers are objective tools with an important role for diagnosis, prognosis and therapy
optimization in patients with heart failure (HF). To date, natriuretic peptides are closest to …

Heart failure (HF) is one of the most common causes of hospitalization and mortality in the
modern Western world and an increasing proportion of the population will be affected by HF …

ABSTRACT Background/Context Heart failure (HF) is a heterogeneous condition
characterized by increased morbidity and mortality. Objective This systematic review and …

Aims The arginine vasopressin (AVP) pathway has been extensively studied in heart failure
(HF) with reduced ejection fraction (HFrEF), but less is known about AVP in HF with …

Introduction Underlying mechanisms of heart failure (HF) with preserved ejection fraction
(HFPEF) remain unknown. We explored copeptin, a biomarker of the arginine vasopressin …

Cardiovascular disease is responsible for the majority of global deaths, posing a grave
threat to human life and health. Consequently, how to diagnosis and monitor the treatement …

Aims: Heart failure (HF) affects approximately 26 million people worldwide. With an aging
global population, innovative approaches to HF evaluation and management are needed to …